BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16978652)

  • 1. Endobronchial donor pre-treatment with ventavis: is a second administration during reperfusion beneficial to optimize post-ischemic function of non-heart beating donor lungs?
    Wittwer T; Franke UF; Sandhaus T; Groetzner J; Strauch JT; Wippermann J; Ochs M; Mühlfeld C; Börner A; Streck S; Wahlers T
    J Surg Res; 2006 Nov; 136(1):136-42. PubMed ID: 16978652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalative pre-treatment of donor lungs using the aerosolized prostacyclin analog iloprost ameliorates reperfusion injury.
    Wittwer T; Franke UF; Ochs M; Sandhaus T; Schuette A; Richter S; Dreyer N; Knudsen L; Müller T; Schubert H; Richter J; Wahlers T
    J Heart Lung Transplant; 2005 Oct; 24(10):1673-9. PubMed ID: 16210146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovative pulmonary preservation of non-heart-beating donor grafts in experimental lung transplantation.
    Wittwer T; Franke UF; Fehrenbach A; Ochs M; Sandhaus T; Dreyer N; Richter J; Wahlers T
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):144-50. PubMed ID: 15200993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor pretreatment using the aerosolized prostacyclin analogue iloprost optimizes post-ischemic function of non-heart beating donor lungs.
    Wittwer T; Franke UF; Fehrenbach A; Ochs M; Sandhaus T; Schuette A; Richter S; Dreyer N; Knudsen L; Müller T; Schubert H; Richter J; Wahlers T
    J Heart Lung Transplant; 2005 Apr; 24(4):371-8. PubMed ID: 15812907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung retrieval from non-heart-beating donors: first experience with an innovative preservation strategy in a pig lung transplantation model.
    Wittwer T; Franke UF; Fehrenbach A; Sandhaus T; Pfeifer F; Dreyer N; Mueller T; Schubert H; Petrow P; Richter J; Wahlers T
    Eur Surg Res; 2004; 36(1):1-7. PubMed ID: 14730216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of donor lung injury in heart-beating versus non-heart-beating donors.
    Neyrinck AP; Van De Wauwer C; Geudens N; Rega FR; Verleden GM; Wouters P; Lerut TE; Van Raemdonck DE
    Eur J Cardiothorac Surg; 2006 Oct; 30(4):628-36. PubMed ID: 16942886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preischemic iloprost application for improvement of graft preservation: which route is superior in experimental pig lung transplantation: inhaled or intravenous?
    Wittwer T; Franke UF; Sandhaus T; Thiene M; Groetzner J; Strauch JT; Wippermann J; Ochs M; Muehlfeld C
    Transplant Proc; 2007 Jun; 39(5):1345-9. PubMed ID: 17580136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nebulized N-acetyl cysteine protects the pulmonary graft inside the non-heart-beating donor.
    Rega FR; Wuyts WA; Vanaudenaerde BM; Jannis NC; Neyrinck AP; Verleden GM; Lerut TE; Van Raemdonck DE
    J Heart Lung Transplant; 2005 Sep; 24(9):1369-77. PubMed ID: 16143259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-arrest administration of the cell-permeable free radical scavenger tempol reduces warm ischemic damage of lung function in non-heart-beating donors.
    Hodyc D; Hnilickova O; Hampl V; Herget J
    J Heart Lung Transplant; 2008 Aug; 27(8):890-7. PubMed ID: 18656803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDE-5 inhibitor donor intravenous preconditioning is superior to supplementation in standard preservation solution in experimental lung transplantation.
    Pizanis N; Milekhin V; Tsagakis K; Aleksic I; Kamler M; Jakob H
    Eur J Cardiothorac Surg; 2007 Jul; 32(1):42-7. PubMed ID: 17482829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic treatment improves the quality of lungs retrieved from non-heart-beating donors.
    Inci I; Zhai W; Arni S; Inci D; Hillinger S; Lardinois D; Vogt P; Weder W
    J Heart Lung Transplant; 2007 Oct; 26(10):1054-60. PubMed ID: 17919627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary function after non-heart-beating lung donation in a survival model.
    Buchanan SA; DeLima NF; Binns OA; Mauney MC; Cope JT; Langenburg SE; Shockey KS; Bianchi JD; Parekh VI; Tribble CG
    Ann Thorac Surg; 1995 Jul; 60(1):38-44; discussion 44-6. PubMed ID: 7598619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental lung transplantation: impact of preservation solution and route of delivery.
    Wittwer T; Franke UF; Fehrenbach A; Ochs M; Sandhaus T; Schuette A; Richter S; Dreyer N; Knudsen L; Müller T; Schubert H; Richter J; Wahlers T
    J Heart Lung Transplant; 2005 Aug; 24(8):1081-90. PubMed ID: 16102444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant application in experimental lung transplantation.
    Wittwer T; Madershahian N; Rahmanian P; Choi YH; Neef K; Frank K; Müller-Ehmsen J; Ochs M; Mühlfeld C; Wahlers T
    J Heart Lung Transplant; 2013 Mar; 32(3):355-9. PubMed ID: 23313558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrograde flush following warm ischemia in the non-heart-beating donor results in superior graft performance at reperfusion.
    Van De Wauwer C; Neyrinck AP; Geudens N; Rega FR; Verleden GM; Verbeken E; Lerut TE; Van Raemdonck DE
    J Surg Res; 2009 Jun; 154(1):118-25. PubMed ID: 19201425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sildenafil extends survival and graft function in a large animal lung transplantation model.
    Korom S; Hillinger S; Cardell M; Zhai W; Tan Q; Dutly A; Leskosek B; Weder W
    Eur J Cardiothorac Surg; 2006 Mar; 29(3):288-93. PubMed ID: 16442298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cell pretreatment of non-heart-beating-donors in experimental lung transplantation.
    Wittwer T; Rahmanian P; Choi YH; Zeriouh M; Karavidic S; Neef K; Christmann A; Piatkowski T; Schnapper A; Ochs M; Mühlfeld C; Wahlers T
    J Cardiothorac Surg; 2014 Sep; 9():151. PubMed ID: 25179441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iloprost to improve surfactant function in porcine pulmonary grafts stored for twenty-four hours in low-potassium dextran solution.
    Gohrbandt B; Sommer SP; Fischer S; Hohlfeld JM; Warnecke G; Haverich A; Strueber M
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):80-6. PubMed ID: 15632828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled nitric oxide reduces ischemia-reperfusion injury in rat lungs from non-heart-beating donors.
    Takashima S; Koukoulis G; Inokawa H; Sevala M; Egan TM
    J Thorac Cardiovasc Surg; 2006 Jul; 132(1):132-9. PubMed ID: 16798313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrograde flush following topical cooling is superior to preserve the non-heart-beating donor lung.
    Van De Wauwer C; Neyrinck AP; Geudens N; Rega FR; Verleden GM; Verbeken E; Lerut TE; Van Raemdonck DE
    Eur J Cardiothorac Surg; 2007 Jun; 31(6):1125-32; discussion 1132-3. PubMed ID: 17360192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.